Propane

Propane

SCHEMBL787113

CCC.F.F.F.F.F.F.F.F

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.38
ALDH1A1 P00352 2/20 0.38
LMNA P02545 1/20 0.33
THRB P10828 1/20 0.30
NFKB1 P19838 1/20 0.30
KCNA1 Q09470 1/20 0.30
TDP1 Q9NUW8 1/20 0.30
TP53 P04637 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propane SCHEMBL11764249 1.00 TSHR (0.38) TSHRALDH1A1LMNATHRBNFKB1
Propane SCHEMBL8444696 1.00
Propane SCHEMBL27735195 1.00
Propane SCHEMBL28758767 1.00
Propane SCHEMBL28670151 1.00
Propane SCHEMBL7997861 1.00 TSHR (0.38) TSHRALDH1A1LMNATHRBNFKB1
Propane SCHEMBL7708559 1.00
Propane SCHEMBL787112 1.00 TSHR (0.38) TSHRALDH1A1LMNATHRBNFKB1
Propane SCHEMBL27793722 0.91
Propane SCHEMBL27383303 0.91 ALDH1A1 (0.33) TSHRALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11830741-B2 Method for forming film TOKYO ELECTRON LIMITED (JP) 2023-11-28 US claimed
US-20220189778-A1 METHOD FOR FORMING FILM TOKYO ELECTRON LIMITED (JP) 2022-06-16 US claimed
US-11219598-B2 Ophthalmic drug sustained release device PUBLIC UNIVERSITY CORPORATION NAGOYA CITY UNIVERSITY (JP) 2022-01-11 US claimed
US-10692729-B2 Etching process method TOKYO ELECTRON LIMITED (JP) 2020-06-23 US claimed
US-20190099366-A1 OPHTHALMIC DRUG SUSTAINED RELEASE DEVICE YASUKAWA, TSUTOMU (JP) 2019-04-04 US claimed
EP-3453366-A1 OPHTHALMIC DRUG SUSTAINED RELEASE DEVICE Public University Corporation Nagoya City University (JP) 2019-03-13 EP claimed
US-20170372916-A1 ETCHING PROCESS METHOD TOKYO ELECTRON LIMITED (JP) 2017-12-28 US claimed
US-8039204-B2 Manufacturing method of silicon carbide semiconductor apparatus MITSUBISHI ELECTRIC CORPORATION (JP) 2011-10-18 US claimed
US-6869732-B2 Glass substrate for photomasks and preparation method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2005-03-22 US claimed
US-6855908-B2 Glass substrate and leveling thereof SHIN-ETSU CHEMICAL CO., LTD. (JP) 2005-02-15 US claimed
US-12592367-B2 Plasma processing apparatus and manufacturing method of wafer stage for plasma processing apparatus HITACHI HIGH-TECH CORPORATION (JP) 2026-03-31 US disclosed
US-12537175-B2 Semiconductor device manufacturing system and semiconductor device manufacturing method HITACHI HIGH-TECH CORPORATION (JP) 2026-01-27 US disclosed
US-20260011538-A1 SEMICONDUCTOR DEVICE MANUFACTURING SYSTEM AND SEMICONDUCTOR DEVICE MANUFACTURING METHOD HITACHI HIGH TECH COPORATION (JP) 2026-01-08 US disclosed
EP-4241799-B1 METAL MATERIAL FOR MEDICAL DEVICE, MANUFACTURING METHOD FOR METAL MATERIAL FOR MEDICAL DEVICE, AND MEDICAL DEVICE GLOBAL VASCULAR CO LTD (JP) 2025-10-22 EP disclosed
US-20250218790-A1 METHOD OF MANUFACTURING SEMICONDUCTOR DEVICE, METHOD OF PROCESSING SUBSTRATE, SUBSTRATE PROCESSING APPARATUS, AND RECORDING MEDIUM Kokusai Electric Corporation (JP) 2025-07-03 US disclosed
US-5536298-A Method of treating fine particle dust in manufacturing process of semiconductor elements and apparatus therefor AWAJI TOSHIO (JP) 1996-07-16 US disclosed
US-5514205-A Apparatus for removing harmful objects from a gas AWAJI TOSHIO (JP) 1996-05-07 US disclosed
US-4680045-A OPTICAL FIBERS SEIKO EPSON KABUSHIKI KAISHA (JP) 1987-07-14 US disclosed
US-4680048-A OPTICAL FIBERS SEIKO EPSON KABUSHIKI KAISHA (JP) 1987-07-14 US disclosed
US-4680046-A DOPED SILICA GLASS SEIKO EPSON KABUSHIKI KAISHA (JP) 1987-07-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12592367-B2 Plasma processing apparatus and manufacturing method of wafer stage for plasma processing apparatus C9, PRF1, LNPK TSHR 3390/4885ALDH1A1 2890/4885LMNA 533/4885
US-20260011538-A1 SEMICONDUCTOR DEVICE MANUFACTURING SYSTEM AND SEMICONDUCTOR DEVICE MANUFACTURING METHOD ESPL1, PIEZO1, EXOSC4 TSHR 2958/4885ALDH1A1 4435/4885LMNA 3964/4885
US-12537175-B2 Semiconductor device manufacturing system and semiconductor device manufacturing method SEM1, ESPL1, PIEZO1 TSHR 1385/4885ALDH1A1 2631/4885LMNA 4400/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.